KLK3 and neoplasm: In addition, tumor-derived exosomes enriched with KLK3 (prostate-specific antigen) or interleukin-8 contribute to the suppression of T-cell cytotoxicity through mechanisms involving metabolic reprogramming and direct inhibitory signaling [29,30].